nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Nucleoside Analog—Azathioprine—systemic scleroderma	0.836	1	CiPCiCtD
Didanosine—SLC22A6—Captopril—systemic scleroderma	0.0414	0.76	CbGbCtD
Didanosine—SLC22A6—Methotrexate—systemic scleroderma	0.0131	0.24	CbGbCtD
Didanosine—PNP—Clobetasol propionate—Mometasone—systemic scleroderma	0.000528	0.188	CbGdCrCtD
Didanosine—PNP—Flunisolide—Mometasone—systemic scleroderma	0.000521	0.185	CbGdCrCtD
Didanosine—PNP—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000503	0.179	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.000474	0.168	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Prednisone—systemic scleroderma	0.000288	0.102	CbGdCrCtD
Didanosine—PNP—Flunisolide—Prednisone—systemic scleroderma	0.000284	0.101	CbGdCrCtD
Didanosine—Flatulence—Leflunomide—systemic scleroderma	0.000227	0.00212	CcSEcCtD
Didanosine—Chills—Mycophenolic acid—systemic scleroderma	0.000226	0.00212	CcSEcCtD
Didanosine—Decreased appetite—Mometasone—systemic scleroderma	0.000226	0.00211	CcSEcCtD
Didanosine—Anaemia—Azathioprine—systemic scleroderma	0.000225	0.00211	CcSEcCtD
Didanosine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.000225	0.0021	CcSEcCtD
Didanosine—Diabetes mellitus—Prednisone—systemic scleroderma	0.000224	0.0021	CcSEcCtD
Didanosine—Thrombocytopenia—Captopril—systemic scleroderma	0.000223	0.00209	CcSEcCtD
Didanosine—Alopecia—Mycophenolic acid—systemic scleroderma	0.000223	0.00209	CcSEcCtD
Didanosine—Pain—Mometasone—systemic scleroderma	0.000222	0.00208	CcSEcCtD
Didanosine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000222	0.00207	CcSEcCtD
Didanosine—Malaise—Azathioprine—systemic scleroderma	0.00022	0.00206	CcSEcCtD
Didanosine—Leukopenia—Azathioprine—systemic scleroderma	0.000218	0.00204	CcSEcCtD
Didanosine—PNP—Danazol—Prednisone—systemic scleroderma	0.000218	0.0773	CbGdCrCtD
Didanosine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00203	CcSEcCtD
Didanosine—Anorexia—Captopril—systemic scleroderma	0.000217	0.00203	CcSEcCtD
Didanosine—Flatulence—Mycophenolic acid—systemic scleroderma	0.000217	0.00203	CcSEcCtD
Didanosine—Asthenia—Pentoxifylline—systemic scleroderma	0.000216	0.00202	CcSEcCtD
Didanosine—Pruritus—Pentoxifylline—systemic scleroderma	0.000213	0.00199	CcSEcCtD
Didanosine—Anaemia—Leflunomide—systemic scleroderma	0.000213	0.00199	CcSEcCtD
Didanosine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000212	0.00199	CcSEcCtD
Didanosine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00021	0.00196	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000208	0.00194	CcSEcCtD
Didanosine—Malaise—Leflunomide—systemic scleroderma	0.000208	0.00194	CcSEcCtD
Didanosine—Myalgia—Azathioprine—systemic scleroderma	0.000208	0.00194	CcSEcCtD
Didanosine—Arthralgia—Azathioprine—systemic scleroderma	0.000208	0.00194	CcSEcCtD
Didanosine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000207	0.00194	CcSEcCtD
Didanosine—Leukopenia—Leflunomide—systemic scleroderma	0.000206	0.00193	CcSEcCtD
Didanosine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000206	0.00193	CcSEcCtD
Didanosine—Abdominal pain—Mometasone—systemic scleroderma	0.000205	0.00192	CcSEcCtD
Didanosine—Body temperature increased—Mometasone—systemic scleroderma	0.000205	0.00192	CcSEcCtD
Didanosine—Discomfort—Azathioprine—systemic scleroderma	0.000205	0.00192	CcSEcCtD
Didanosine—Paraesthesia—Captopril—systemic scleroderma	0.000205	0.00192	CcSEcCtD
Didanosine—Chills—Lisinopril—systemic scleroderma	0.000204	0.00191	CcSEcCtD
Didanosine—Anaemia—Mycophenolic acid—systemic scleroderma	0.000203	0.0019	CcSEcCtD
Didanosine—Alopecia—Lisinopril—systemic scleroderma	0.000201	0.00188	CcSEcCtD
Didanosine—Dyspepsia—Captopril—systemic scleroderma	0.000201	0.00188	CcSEcCtD
Didanosine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00186	CcSEcCtD
Didanosine—Decreased appetite—Captopril—systemic scleroderma	0.000198	0.00185	CcSEcCtD
Didanosine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00185	CcSEcCtD
Didanosine—Malaise—Mycophenolic acid—systemic scleroderma	0.000198	0.00185	CcSEcCtD
Didanosine—Infection—Azathioprine—systemic scleroderma	0.000198	0.00185	CcSEcCtD
Didanosine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000197	0.00184	CcSEcCtD
Didanosine—Arthralgia—Leflunomide—systemic scleroderma	0.000196	0.00183	CcSEcCtD
Didanosine—Myalgia—Leflunomide—systemic scleroderma	0.000196	0.00183	CcSEcCtD
Didanosine—Flatulence—Lisinopril—systemic scleroderma	0.000195	0.00182	CcSEcCtD
Didanosine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000195	0.00182	CcSEcCtD
Didanosine—Discomfort—Leflunomide—systemic scleroderma	0.000194	0.00181	CcSEcCtD
Didanosine—Dry mouth—Leflunomide—systemic scleroderma	0.000192	0.00179	CcSEcCtD
Didanosine—Vomiting—Pentoxifylline—systemic scleroderma	0.000191	0.00179	CcSEcCtD
Didanosine—Rash—Pentoxifylline—systemic scleroderma	0.00019	0.00177	CcSEcCtD
Didanosine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00019	0.00177	CcSEcCtD
Didanosine—Headache—Pentoxifylline—systemic scleroderma	0.000189	0.00176	CcSEcCtD
Didanosine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000188	0.00176	CcSEcCtD
Didanosine—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000188	0.00175	CcSEcCtD
Didanosine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000187	0.00175	CcSEcCtD
Didanosine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000187	0.00175	CcSEcCtD
Didanosine—Infection—Leflunomide—systemic scleroderma	0.000187	0.00175	CcSEcCtD
Didanosine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000187	0.00174	CcSEcCtD
Didanosine—Asthenia—Mometasone—systemic scleroderma	0.000186	0.00174	CcSEcCtD
Didanosine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000185	0.00173	CcSEcCtD
Didanosine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000184	0.00172	CcSEcCtD
Didanosine—Pruritus—Mometasone—systemic scleroderma	0.000184	0.00172	CcSEcCtD
Didanosine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000183	0.00171	CcSEcCtD
Didanosine—Anaemia—Lisinopril—systemic scleroderma	0.000183	0.00171	CcSEcCtD
Didanosine—Hepatic failure—Methotrexate—systemic scleroderma	0.000182	0.0017	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000181	0.0017	CcSEcCtD
Didanosine—Abdominal pain—Captopril—systemic scleroderma	0.00018	0.00169	CcSEcCtD
Didanosine—Body temperature increased—Captopril—systemic scleroderma	0.00018	0.00169	CcSEcCtD
Didanosine—Anorexia—Leflunomide—systemic scleroderma	0.000179	0.00168	CcSEcCtD
Didanosine—Nausea—Pentoxifylline—systemic scleroderma	0.000179	0.00167	CcSEcCtD
Didanosine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00167	CcSEcCtD
Didanosine—Malaise—Lisinopril—systemic scleroderma	0.000178	0.00167	CcSEcCtD
Didanosine—Infection—Mycophenolic acid—systemic scleroderma	0.000178	0.00167	CcSEcCtD
Didanosine—Diarrhoea—Mometasone—systemic scleroderma	0.000178	0.00166	CcSEcCtD
Didanosine—Leukopenia—Lisinopril—systemic scleroderma	0.000177	0.00166	CcSEcCtD
Didanosine—Renal failure acute—Methotrexate—systemic scleroderma	0.000177	0.00165	CcSEcCtD
Didanosine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00165	CcSEcCtD
Didanosine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000176	0.00164	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000171	0.0016	CcSEcCtD
Didanosine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000171	0.0016	CcSEcCtD
Didanosine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000171	0.0016	CcSEcCtD
Didanosine—Paraesthesia—Leflunomide—systemic scleroderma	0.000169	0.00158	CcSEcCtD
Didanosine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000169	0.00158	CcSEcCtD
Didanosine—Arthralgia—Lisinopril—systemic scleroderma	0.000169	0.00158	CcSEcCtD
Didanosine—Myalgia—Lisinopril—systemic scleroderma	0.000169	0.00158	CcSEcCtD
Didanosine—Discomfort—Lisinopril—systemic scleroderma	0.000166	0.00156	CcSEcCtD
Didanosine—Dyspepsia—Leflunomide—systemic scleroderma	0.000165	0.00155	CcSEcCtD
Didanosine—Pancreatitis—Prednisone—systemic scleroderma	0.000165	0.00155	CcSEcCtD
Didanosine—Vomiting—Mometasone—systemic scleroderma	0.000165	0.00154	CcSEcCtD
Didanosine—Dry mouth—Lisinopril—systemic scleroderma	0.000165	0.00154	CcSEcCtD
Didanosine—Rash—Mometasone—systemic scleroderma	0.000164	0.00153	CcSEcCtD
Didanosine—Asthenia—Captopril—systemic scleroderma	0.000164	0.00153	CcSEcCtD
Didanosine—Dermatitis—Mometasone—systemic scleroderma	0.000164	0.00153	CcSEcCtD
Didanosine—Decreased appetite—Leflunomide—systemic scleroderma	0.000163	0.00153	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000163	0.00153	CcSEcCtD
Didanosine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000163	0.00152	CcSEcCtD
Didanosine—Headache—Mometasone—systemic scleroderma	0.000163	0.00152	CcSEcCtD
Didanosine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000162	0.00151	CcSEcCtD
Didanosine—Pruritus—Captopril—systemic scleroderma	0.000161	0.00151	CcSEcCtD
Didanosine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000161	0.00151	CcSEcCtD
Didanosine—Pain—Leflunomide—systemic scleroderma	0.000161	0.0015	CcSEcCtD
Didanosine—Infection—Lisinopril—systemic scleroderma	0.00016	0.0015	CcSEcCtD
Didanosine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.0015	CcSEcCtD
Didanosine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000158	0.00148	CcSEcCtD
Didanosine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000158	0.00148	CcSEcCtD
Didanosine—Abdominal pain—Azathioprine—systemic scleroderma	0.000157	0.00147	CcSEcCtD
Didanosine—Body temperature increased—Azathioprine—systemic scleroderma	0.000157	0.00147	CcSEcCtD
Didanosine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00146	CcSEcCtD
Didanosine—Diarrhoea—Captopril—systemic scleroderma	0.000156	0.00146	CcSEcCtD
Didanosine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000156	0.00146	CcSEcCtD
Didanosine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000155	0.00145	CcSEcCtD
Didanosine—Nausea—Mometasone—systemic scleroderma	0.000154	0.00144	CcSEcCtD
Didanosine—Anorexia—Lisinopril—systemic scleroderma	0.000154	0.00144	CcSEcCtD
Didanosine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000154	0.00144	CcSEcCtD
Didanosine—Pain—Mycophenolic acid—systemic scleroderma	0.000153	0.00143	CcSEcCtD
Didanosine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000152	0.00142	CcSEcCtD
Didanosine—Body temperature increased—Leflunomide—systemic scleroderma	0.000149	0.00139	CcSEcCtD
Didanosine—Abdominal pain—Leflunomide—systemic scleroderma	0.000149	0.00139	CcSEcCtD
Didanosine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00138	CcSEcCtD
Didanosine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00138	CcSEcCtD
Didanosine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000147	0.00138	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000147	0.00138	CcSEcCtD
Didanosine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000147	0.00137	CcSEcCtD
Didanosine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000147	0.00137	CcSEcCtD
Didanosine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00136	CcSEcCtD
Didanosine—Paraesthesia—Lisinopril—systemic scleroderma	0.000145	0.00136	CcSEcCtD
Didanosine—Vomiting—Captopril—systemic scleroderma	0.000145	0.00136	CcSEcCtD
Didanosine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000144	0.00135	CcSEcCtD
Didanosine—Rash—Captopril—systemic scleroderma	0.000144	0.00135	CcSEcCtD
Didanosine—Dermatitis—Captopril—systemic scleroderma	0.000144	0.00134	CcSEcCtD
Didanosine—Headache—Captopril—systemic scleroderma	0.000143	0.00134	CcSEcCtD
Didanosine—Dyspepsia—Lisinopril—systemic scleroderma	0.000142	0.00133	CcSEcCtD
Didanosine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000142	0.00133	CcSEcCtD
Didanosine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000142	0.00133	CcSEcCtD
Didanosine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000142	0.00132	CcSEcCtD
Didanosine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00132	CcSEcCtD
Didanosine—Decreased appetite—Lisinopril—systemic scleroderma	0.00014	0.00131	CcSEcCtD
Didanosine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.0013	CcSEcCtD
Didanosine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000139	0.0013	CcSEcCtD
Didanosine—Pancreatitis—Methotrexate—systemic scleroderma	0.000138	0.00129	CcSEcCtD
Didanosine—Pain—Lisinopril—systemic scleroderma	0.000138	0.00129	CcSEcCtD
Didanosine—Diarrhoea—Azathioprine—systemic scleroderma	0.000136	0.00127	CcSEcCtD
Didanosine—Nausea—Captopril—systemic scleroderma	0.000135	0.00127	CcSEcCtD
Didanosine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000135	0.00126	CcSEcCtD
Didanosine—Asthenia—Leflunomide—systemic scleroderma	0.000135	0.00126	CcSEcCtD
Didanosine—Pruritus—Leflunomide—systemic scleroderma	0.000133	0.00124	CcSEcCtD
Didanosine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000132	0.00124	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00121	CcSEcCtD
Didanosine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000129	0.0012	CcSEcCtD
Didanosine—Diarrhoea—Leflunomide—systemic scleroderma	0.000129	0.0012	CcSEcCtD
Didanosine—Body temperature increased—Lisinopril—systemic scleroderma	0.000128	0.00119	CcSEcCtD
Didanosine—Abdominal pain—Lisinopril—systemic scleroderma	0.000128	0.00119	CcSEcCtD
Didanosine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00119	CcSEcCtD
Didanosine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000127	0.00119	CcSEcCtD
Didanosine—Vomiting—Azathioprine—systemic scleroderma	0.000127	0.00118	CcSEcCtD
Didanosine—Rash—Azathioprine—systemic scleroderma	0.000126	0.00117	CcSEcCtD
Didanosine—Dermatitis—Azathioprine—systemic scleroderma	0.000125	0.00117	CcSEcCtD
Didanosine—Headache—Azathioprine—systemic scleroderma	0.000125	0.00117	CcSEcCtD
Didanosine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000125	0.00117	CcSEcCtD
Didanosine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000123	0.00115	CcSEcCtD
Didanosine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000123	0.00115	CcSEcCtD
Didanosine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000121	0.00113	CcSEcCtD
Didanosine—Vomiting—Leflunomide—systemic scleroderma	0.00012	0.00112	CcSEcCtD
Didanosine—Alopecia—Prednisone—systemic scleroderma	0.000119	0.00112	CcSEcCtD
Didanosine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000119	0.00111	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000119	0.00111	CcSEcCtD
Didanosine—Rash—Leflunomide—systemic scleroderma	0.000119	0.00111	CcSEcCtD
Didanosine—Dermatitis—Leflunomide—systemic scleroderma	0.000118	0.00111	CcSEcCtD
Didanosine—Nausea—Azathioprine—systemic scleroderma	0.000118	0.00111	CcSEcCtD
Didanosine—Headache—Leflunomide—systemic scleroderma	0.000118	0.0011	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000117	0.0011	CcSEcCtD
Didanosine—Asthenia—Lisinopril—systemic scleroderma	0.000116	0.00108	CcSEcCtD
Didanosine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000116	0.00108	CcSEcCtD
Didanosine—Pruritus—Lisinopril—systemic scleroderma	0.000114	0.00107	CcSEcCtD
Didanosine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000114	0.00107	CcSEcCtD
Didanosine—Rash—Mycophenolic acid—systemic scleroderma	0.000113	0.00106	CcSEcCtD
Didanosine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000113	0.00106	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—systemic scleroderma	0.000113	0.00106	CcSEcCtD
Didanosine—Headache—Mycophenolic acid—systemic scleroderma	0.000112	0.00105	CcSEcCtD
Didanosine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000112	0.00105	CcSEcCtD
Didanosine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000112	0.00105	CcSEcCtD
Didanosine—Nausea—Leflunomide—systemic scleroderma	0.000112	0.00104	CcSEcCtD
Didanosine—Diarrhoea—Lisinopril—systemic scleroderma	0.000111	0.00103	CcSEcCtD
Didanosine—Anaemia—Prednisone—systemic scleroderma	0.000109	0.00102	CcSEcCtD
Didanosine—Nausea—Mycophenolic acid—systemic scleroderma	0.000107	0.000996	CcSEcCtD
Didanosine—Malaise—Prednisone—systemic scleroderma	0.000106	0.000991	CcSEcCtD
Didanosine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000975	CcSEcCtD
Didanosine—Vomiting—Lisinopril—systemic scleroderma	0.000103	0.000961	CcSEcCtD
Didanosine—Rash—Lisinopril—systemic scleroderma	0.000102	0.000953	CcSEcCtD
Didanosine—Dermatitis—Lisinopril—systemic scleroderma	0.000102	0.000952	CcSEcCtD
Didanosine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00095	CcSEcCtD
Didanosine—Chills—Methotrexate—systemic scleroderma	0.000101	0.000947	CcSEcCtD
Didanosine—Headache—Lisinopril—systemic scleroderma	0.000101	0.000946	CcSEcCtD
Didanosine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000937	CcSEcCtD
Didanosine—Arthralgia—Prednisone—systemic scleroderma	0.0001	0.000936	CcSEcCtD
Didanosine—Myalgia—Prednisone—systemic scleroderma	0.0001	0.000936	CcSEcCtD
Didanosine—Alopecia—Methotrexate—systemic scleroderma	9.97e-05	0.000933	CcSEcCtD
Didanosine—Discomfort—Prednisone—systemic scleroderma	9.89e-05	0.000925	CcSEcCtD
Didanosine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	9.68e-05	0.000906	CcSEcCtD
Didanosine—Nausea—Lisinopril—systemic scleroderma	9.6e-05	0.000897	CcSEcCtD
Didanosine—Anaphylactic shock—Prednisone—systemic scleroderma	9.59e-05	0.000897	CcSEcCtD
Didanosine—Infection—Prednisone—systemic scleroderma	9.53e-05	0.000891	CcSEcCtD
Didanosine—Anorexia—Prednisone—systemic scleroderma	9.14e-05	0.000855	CcSEcCtD
Didanosine—Anaemia—Methotrexate—systemic scleroderma	9.08e-05	0.000849	CcSEcCtD
Didanosine—Vomiting—Mycophenolate mofetil—systemic scleroderma	9e-05	0.000842	CcSEcCtD
Didanosine—Rash—Mycophenolate mofetil—systemic scleroderma	8.92e-05	0.000835	CcSEcCtD
Didanosine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	8.92e-05	0.000834	CcSEcCtD
Didanosine—Headache—Mycophenolate mofetil—systemic scleroderma	8.87e-05	0.000829	CcSEcCtD
Didanosine—Malaise—Methotrexate—systemic scleroderma	8.86e-05	0.000829	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—systemic scleroderma	8.79e-05	0.000822	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	8.74e-05	0.000818	CcSEcCtD
Didanosine—Paraesthesia—Prednisone—systemic scleroderma	8.61e-05	0.000806	CcSEcCtD
Didanosine—Dyspepsia—Prednisone—systemic scleroderma	8.45e-05	0.00079	CcSEcCtD
Didanosine—Nausea—Mycophenolate mofetil—systemic scleroderma	8.41e-05	0.000786	CcSEcCtD
Didanosine—Myalgia—Methotrexate—systemic scleroderma	8.36e-05	0.000782	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—systemic scleroderma	8.36e-05	0.000782	CcSEcCtD
Didanosine—Decreased appetite—Prednisone—systemic scleroderma	8.34e-05	0.00078	CcSEcCtD
Didanosine—Discomfort—Methotrexate—systemic scleroderma	8.26e-05	0.000773	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—systemic scleroderma	8.02e-05	0.00075	CcSEcCtD
Didanosine—Infection—Methotrexate—systemic scleroderma	7.97e-05	0.000745	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—systemic scleroderma	7.85e-05	0.000734	CcSEcCtD
Didanosine—Gastrointestinal pain—Prednisone—systemic scleroderma	7.85e-05	0.000734	CcSEcCtD
Didanosine—Anorexia—Methotrexate—systemic scleroderma	7.64e-05	0.000715	CcSEcCtD
Didanosine—Abdominal pain—Prednisone—systemic scleroderma	7.58e-05	0.000709	CcSEcCtD
Didanosine—Body temperature increased—Prednisone—systemic scleroderma	7.58e-05	0.000709	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.3e-05	0.000683	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—systemic scleroderma	7.2e-05	0.000673	CcSEcCtD
Didanosine—Hypersensitivity—Prednisone—systemic scleroderma	7.07e-05	0.000661	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—systemic scleroderma	7.06e-05	0.00066	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—systemic scleroderma	6.97e-05	0.000652	CcSEcCtD
Didanosine—Asthenia—Prednisone—systemic scleroderma	6.88e-05	0.000644	CcSEcCtD
Didanosine—Pain—Methotrexate—systemic scleroderma	6.86e-05	0.000641	CcSEcCtD
Didanosine—Pruritus—Prednisone—systemic scleroderma	6.79e-05	0.000635	CcSEcCtD
Didanosine—Diarrhoea—Prednisone—systemic scleroderma	6.56e-05	0.000614	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.56e-05	0.000613	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—systemic scleroderma	6.34e-05	0.000593	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—systemic scleroderma	6.34e-05	0.000593	CcSEcCtD
Didanosine—Vomiting—Prednisone—systemic scleroderma	6.1e-05	0.000571	CcSEcCtD
Didanosine—Rash—Prednisone—systemic scleroderma	6.05e-05	0.000566	CcSEcCtD
Didanosine—Dermatitis—Prednisone—systemic scleroderma	6.04e-05	0.000565	CcSEcCtD
Didanosine—Headache—Prednisone—systemic scleroderma	6.01e-05	0.000562	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—systemic scleroderma	5.91e-05	0.000553	CcSEcCtD
Didanosine—Asthenia—Methotrexate—systemic scleroderma	5.75e-05	0.000538	CcSEcCtD
Didanosine—Nausea—Prednisone—systemic scleroderma	5.7e-05	0.000533	CcSEcCtD
Didanosine—Pruritus—Methotrexate—systemic scleroderma	5.67e-05	0.000531	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—systemic scleroderma	5.49e-05	0.000513	CcSEcCtD
Didanosine—Vomiting—Methotrexate—systemic scleroderma	5.1e-05	0.000477	CcSEcCtD
Didanosine—Rash—Methotrexate—systemic scleroderma	5.06e-05	0.000473	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—systemic scleroderma	5.05e-05	0.000472	CcSEcCtD
Didanosine—Headache—Methotrexate—systemic scleroderma	5.02e-05	0.00047	CcSEcCtD
Didanosine—Nausea—Methotrexate—systemic scleroderma	4.76e-05	0.000445	CcSEcCtD
